The cost of relapse for patients with a manic/mixed episode of bipolar disorder in the EMBLEM study
Please note: this is a legacy publication from CPEC (formely PSSRU at LSE).Pharmacoeconomics 28 7 555-566
Available online: 23 September 2012
Pharmacoeconomics 28 7 555-566
Available online: 23 September 2012